ANAHEIM, California, January 31, 2013 /PRNewswire/ --
More than 500 high-level MedTech professionals in all functions, and from all over the world, will convene at the 2013 MD&M West Conference. MD&M West is one of the most anticipated face-to-face gatherings for those involved in medical device design and manufacturing. The four-day Conference takes place Feb. 11-14, 2013 at the Anaheim Convention Center. To reserve your space, visit http://www.MDMWestConference.com.
The 2013 Conference will host six FDA/CDRH (Center for Devices and Radiological Health) officials, who will be speaking on timely medical device industry topics:
Acting Chief Medical Officer, Office of Device Evaluation, FDA/CDRH
Topic: FDASIA Recap: Clarifying the review process and the benefit-risk determinations for PMA and de novo applications
Don St. Pierre
Deputy Director for New Product Evaluation, Office of In Vitro Diagnostic Device Evaluation & Safety, FDA/CDRH
Topic: Reviewing the 510(k) Triage and Quick Review pilot program and an update on the new process, including the RTA policy change
District Director, FDA Los Angeles District
Topic: FDA Los Angeles District Update and the FDA Globalization Initiative
Director of Import Operations, FDA Los Angeles District
Topic: Update on Los Angeles Import Operations Activities
Team Leader; Human Factors Pre-Market Evaluation Team, Office of Device Evaluation, FDA/CDRH
|SOURCE UBM Canon|
Copyright©2012 PR Newswire.
All rights reserved